Drug development is among the slowest, most failure-prone processes in modern science, with about 90% of drug candidates never reaching the market. Today, artificial intelligence methods have accelerated the first step—plucking promising molecules out of endless possibilities—but countless challenges remain. A successful drug must be not only safe and effective but also able to bypass the body’s defenses and reach the right target.
Originally published at phys.org
Source: Phys.org – latest science and technology news stories
